0001209191-19-013906.txt : 20190226
0001209191-19-013906.hdr.sgml : 20190226
20190226214344
ACCESSION NUMBER: 0001209191-19-013906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190224
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haasner Dirk
CENTRAL INDEX KEY: 0001704660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 19635646
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-24
0
0001636651
Ovid Therapeutics Inc.
OVID
0001704660
Haasner Dirk
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
0
1
0
0
SVP, Global Regulatory Affairs
Employee Stock Option (Right to Buy)
1.89
2019-02-24
4
A
0
75000
0.00
A
2029-02-23
Common Stock
75000
75000
D
25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
/s/ Danielle Mann for Dirk Haasner by POA
2019-02-26